Paper Details
- Home
- Paper Details
In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
Author: GongYan Chun, GuoLiang, LiYu Ping, LiZi Ling, LiuZhi Yong, XiongXiang Yuan, ZhouMing
Original Abstract of the Article :
Biotinylated Pluronic F127/poly(lactic acid) block copolymers (B-F127-PLA) were successfully synthesized previously by our group. In the present study, the release behaviors of paclitaxel-loaded B-F127-PLA nanoparticles and their targeting properties to human ovarian carcinoma cells were investigate...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1016/j.ejps.2012.04.011
データ提供：米国国立医学図書館（NLM）
Biotinylated Pluronic F127/poly(lactic acid) Nanoparticles: A Targeted Delivery System
The field of [nanomedicine] focuses on developing innovative drug delivery systems to improve treatment efficacy and minimize side effects. This study investigates the targeting properties of biotinylated Pluronic F127/poly(lactic acid) nanoparticles (B-F127-PLA NPs) for the delivery of paclitaxel, a chemotherapy drug, to human ovarian carcinoma cells. The study uses [in vitro and in vivo methods] to analyze the release behavior, targeting efficiency, and anticancer activity of paclitaxel-loaded B-F127-PLA NPs. The results demonstrate that B-F127-PLA NPs exhibit a targeted delivery approach based on biotin-avidin interactions, demonstrating their potential for specific drug delivery and improved therapeutic outcomes in ovarian cancer treatment.
A New Path in the Desert of Cancer Treatment: Targeted Delivery Systems
This study reveals the potential of B-F127-PLA NPs as a targeted drug delivery system for ovarian cancer. The researchers found that these nanoparticles effectively deliver paclitaxel to cancer cells, exhibiting a promising approach for improving treatment efficacy and potentially minimizing side effects. This research highlights the potential of nanotechnology to revolutionize cancer treatment, offering a more precise and targeted approach to fighting this complex disease.
Nanotechnology: A Beacon of Hope in the Fight Against Cancer
The desert of cancer treatment is vast and complex, but nanotechnology offers a beacon of hope. This study demonstrates the potential of targeted drug delivery systems, such as B-F127-PLA NPs, to enhance treatment efficacy and improve patient outcomes. The research highlights the promise of nanotechnology in revolutionizing cancer treatment, offering a more precise and individualized approach to fighting this devastating disease.
Dr. Camel's Conclusion
This study demonstrates the potential of B-F127-PLA NPs as a promising targeted drug delivery system for ovarian cancer. It's like discovering a hidden oasis in the desert of cancer treatment, offering a new and more effective way to deliver chemotherapy drugs. This research underscores the power of nanotechnology in revolutionizing cancer treatment, providing a glimmer of hope for patients facing this challenging disease.
Date :
- Date Completed 2012-09-11
- Date Revised 2015-11-19
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.